Advertisement

Header Utility Menu

  • Subscribe
  • Advertise
  • Contact Us
  • Events

LinkedIn Facebook Twitter Instagram Get Our App

  • Login

Virginia Business

Mobile Menu

  • Issues
  • Industries
    • Banking/Finances
    • Law
    • Real Estate
    • Economic Development
    • Education
    • Energy/Green
    • Federal Contracting
    • Government
    • Healthcare
    • Hotels/Tourism
    • Insurance
    • Ports/Trade
    • Small Business
    • Startups
    • Technology
    • Transportation
  • Regions
    • Central Virginia
    • Eastern Virginia
    • Northern Virginia
    • Roanoke/New River Valley
    • Shenandoah Valley
    • Southern Virginia
    • Southwest Virginia
  • Reports
    • Best Places to Work
    • Business Person of the Year
    • CEO Pay
    • COVID-19
    • Generous Virginians Project
    • Legal Elite
    • Most Influential Virginians
    • Maritime Guide
    • Site Locator
    • The Big Book
    • Virginia CFO Awards
  • Company News
    • For the Record
    • People
  • Opinion
  • Lists
  • Awards/Events
    • 2022 Virginia Business Political Roundtable
    • Women in Leadership
    • Diversity Leadership Series
    • Virginia 500
    • Legal Elite
    • CFO Awards
    • Big Book of Lists
    • 100 People To Meet
    • Best Places To Work
  • Virginia 500
    • Read The Issue
    • Power Up Virginia 500
    • Buy an award plaque
    • Suggest execs for 2023

Advertisement

Header Primary Menu

  • Issues
    • February 2023
    • January 2023
    • December 2022
    • November 2022
    • October 2022
    • Issues Archive
  • Industries
    • Banking/Finances
    • Law
    • Real Estate
    • Economic Development
    • Education
    • Energy/Green
    • Federal Contracting
    • Government
    • Healthcare
    • Hotels/Tourism
    • Insurance
    • Ports/Trade
    • Small Business
    • Startups
    • Technology
    • Transportation
  • Regions
    • Central Virginia
    • Eastern Virginia
    • Northern Virginia
    • Roanoke/New River Valley
    • Shenandoah Valley
    • Southern Virginia
    • Southwest Virginia
  • Reports
    • Best Places to Work
    • Business Person of the Year
    • CEO Pay
    • COVID-19
    • Generous Virginians Project
    • Legal Elite
    • Most Influential Virginians
    • Maritime Guide
    • Site Locator
    • The Big Book
    • Virginia CFO Awards
  • Company News
    • For the Record
    • People
  • Opinion
  • Lists
  • Awards/Events
    • 2022 Virginia Business Political Roundtable
    • Women in Leadership
    • Diversity Leadership Series
    • Virginia 500
    • Legal Elite
    • CFO Awards
    • Big Book of Lists
    • 100 People To Meet
    • Best Places To Work
  • Virginia 500
    • Read The Issue
    • Power Up Virginia 500
    • Buy an award plaque
    • Suggest execs for 2023

Home News Industries Healthcare U.Va., VCU researchers battle pandemic

U.Va., VCU researchers battle pandemic

Published April 30, 2020 by Kate Andrews

Photo courtesy Dr. Arun Sanyal

While health care workers scrambled to keep up with the growing number of COVID-19 cases in Virginia, researchers in Charlottesville and Richmond were working to solve the pandemic.

In March, VCU Health liver specialist and cancer researcher Dr. Arun Sanyal began testing remdesivir, an antiviral medication that is showing promise as a treatment for COVID-19.

Along with researchers at several institutions in the United States and in other countries, Sanyal is testing remdesivir on people with moderate to severe virus symptoms. These patients are sick enough to be in the hospital, he says, with documented fever and pneumonia. The worst cases are people who are on ventilators.

As of April 8, there were 22 patients enrolled at VCU Health, a number that changes daily, and the trials, Sanyal says, are “progressing well. Several have already been discharged, and the rest are stable or recovering. We have no deaths in enrolled patients.”

The medication, developed by California-based Gilead Sciences Inc., is given intravenously to patients for five or 10 days in the clinical trials, and Sanyal is tracking the patients’ symptoms. Some moderate patients are given a placebo as a control group.

Once he has results from the trial, Sanyal will send his data to Gilead, which will provide a full analysis of remdesivir to the U.S. Food & Drug Administration for fast-track approval — with the aim of full approval by May or June.

In early April, U.Va. Health joined the national clinical trial for remdesivir sponsored by the National Institutes for Health. In early April, the hospital had enrolled two patients.

Also in Charlottesville, two researchers are working on a COVID-19 vaccine. In late March, Peter Kasson, an infectious disease specialist and associate professor of molecular physiology and biomedical engineering, and Dr. William Petri, a professor and vice chair for research at the U.Va. School of Medicine, were close to testing their vaccine on mice.

Other researchers are slightly ahead in testing COVID-19 vaccines, Kasson notes, but his team and Sanyal are also an important part of a larger effort to lower the number of sick and dead. “I’m hopeful that we can, as a society, leverage some of the technology to slow the spread.”

Subscribe to Virginia Business.

Get our daily e-newsletter.

Related Stories

Virginia Business logo

Canterbury Rehabilitation: Seven confirmed COVID-19 deaths, plus two unconfirmed

Henrico County long-term care facility says 41 residents have tested positive

Virginia Business logo

U.Va. research to inform COVID-19 drug treatment

A 2019 U.Va. study will inform testing of antidepressant as a treatment for virus

Virginia Business logo

VCU scientists studying cancer drug as COVID-19 treatment

AR-12 medication prevents coronavirus from replicating in cells

Trending

13th annual Best Places to Work

Report: Air taxis could land Va. $16B in new biz by 2045

Magical moments

Morrissey’s Petersburg casino bill fails in Senate Finance

Cox expands Myers’ role to East Coast

Sponsored Stories

Working at Pinnacle Financial Partners

What Logistics issues will have the biggest impact on you in 2023?

In the New Year, Aim for Better Cybersecurity

4 innovative ways to create capacity

WHERE IS THE SUPPLY CHAIN WHEN YOU NEED IT?

P.A.I.N.T. Your Financial Mountain

5 Benefits of Treasury Management Services from Atlantic Union Bank

Blazing trails in the digital landscape

Advertisement

Advertisement

Trending

13th annual Best Places to Work

Report: Air taxis could land Va. $16B in new biz by 2045

Magical moments

Morrissey’s Petersburg casino bill fails in Senate Finance

Cox expands Myers’ role to East Coast

Sponsored Stories

Working at Pinnacle Financial Partners

What Logistics issues will have the biggest impact on you in 2023?

In the New Year, Aim for Better Cybersecurity

4 innovative ways to create capacity

WHERE IS THE SUPPLY CHAIN WHEN YOU NEED IT?

P.A.I.N.T. Your Financial Mountain

5 Benefits of Treasury Management Services from Atlantic Union Bank

Blazing trails in the digital landscape

Get Virginia Business directly on your tablet or in your mailbox!

Subscribe to Virginia Business

Advertisement

Advertisement

Footer Primary Menu

  • virginiabusiness.com
  • Subscribe
  • Advertise
  • About Us
  • Contact Us

Footer Secondary Menu

  • Industries
  • Regions
  • Reports
  • Company News
  • Events

Sign Up For Our Newsletter

Sign Up

LinkedIn Facebook Twitter Instagram Get Our App

Privacy Policy Cookie Policy

Footer Utility Menu

Copyright © 2023 Virginia Business. All rights reserved.

Site Maintained by TechArk